← Back
$TERN All transactions

Terns Pharmaceuticals, Inc.

A

$ Value

$0

Shares

68,750

Price

$0

Filed

Jan 16

Insider

Name

Gengos Andrew

Title

Chief Financial Officer

CIK

0001563623

Roles

Officer

Transaction Details

Transaction Date

2026-01-14

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

101,788

Footnotes

Each share is represented by a Restricted Stock Unit ("RSU"). 25% of the RSUs vest on the first anniversary measured from January 1, 2026 (the "Vesting Commencement Date"), and 1/16th of the total number of shares vest quarterly thereafter, such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date. | Includes 8,038 shares acquired by the Reporting Person under the Issuer's 2021 Employee Stock Purchase Plan ("ESPP") on November 30, 2025. | 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.

Filing Info

Accession No.

0001563623-26-000002

Form Type

4

Issuer CIK

0001831363

Gengos Andrew's History

Date Ticker Type Value
2026-01-14 TERN A $0
2026-01-14 TERN A $0
2025-10-08 TTRX A $0
2025-06-27 TERN $20K
2025-06-27 TERN $20K
2025-06-16 TERN $20K
2025-06-13 TERN $19K
2025-06-13 TERN $19K

Other Insiders at TERN (90d)

Insider Bought Sold Last
FELLOWS DAVID A 2026-02-01
KINDLER JEFFREY B 2026-02-01
Turner Heather D 2026-02-01
Azelby Robert 2026-02-01
Tripuraneni Radhika 2026-02-01
Quigley Jill M. 2026-02-01
Burroughs Amy L.
Chief Executive Officer
$572K 2026-02-17
Kuriakose Emil
Chief Medical Officer
$50K 2026-04-01